HLA-C and diffuse large B-cell lymphoma: The phenotypic frequency of HLA-C*12 was significantly lower in the DLBCL group compared to the control population (3.33% vs. 17.9%, OR = 0.16, 95% CI: 0.04–0.44) (Table 2).